Product
Supplier
Encyclopedia
Inquiry
Eloralintide ML buy - large image1
Eloralintide ML buy - image1

Eloralintide ML

GMP ISO COA TDS 36 Inquiries

Unit Price:

$1/G FOB

Get Latest Price
CAS No.:

2883634-40-8

Grade:

Pharmaceutical Grade

Content:

99.4%

Port:

香港

Packaging:

1g/5g/10g/50g/100g

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Amycretin,BI-456906

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Our Eloralintide API is produced through advanced solid-phase peptide synthesis (SPPS) with precise control over
    sequence fidelity, folding efficiency, and impurity levels. As an emerging functional peptide under active development,
    Eloralintide requires strict analytical verification to ensure high purity, structural integrity, and consistency between
    batches.
    We utilize Thermo Fisher UPLC/HPLC/MS analytical systems under an ICH Q7-aligned quality framework to deliver
    reliable R&D-grade and pilot-scale Eloralintide for global partners. With flexible production capacity and fast lead
    times; we support early discovery, formulation development, and preclinical research.

    Items Specifications






    Certificates
    • Eloralintide ML Certificates 4

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Cagrilintide,Amycretin,BI-456906

    Location:

    1603-1, C Building, Wanxia Center, Houhaibin Road, Nanshan, Shenzhen, China

    Payment Terms:

    100% TT in advance

    Average lead Time:

    14

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    201-300

    Year of Establishment:

    2025


      Company Profile  


    ">
  • Inquiry History
    36 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    United States

    Eloralintide

    1 G Jul 13, 2026
    United States

    Eloralintide

    10 PCS Jul 11, 2026
    Singapore

    Eloralintide

    1 G Jul 1, 2026
    United States

    eloralintide

    50 MT Jun 12, 2026
    United States

    Eloralintide and Retatrutide

    2 MT Jun 8, 2026
    United States

    Eloralintide

    5 PCS May 27, 2026
    South Korea

    eloralintide

    2 G Feb 24, 2026
    United States

    Eloralintide

    1 G Feb 20, 2026
    United States

    ELORALINTIDE

    10 MG Feb 19, 2026
    United States

    Eloralintide

    100 PCS Feb 15, 2026
    United Kingdom

    Eloralintide

    10  Dec 28, 2025
    United States

    Eloralintide

    20 MT Jul 23, 2026
    United States

    Eloralintide

    10 MG Jul 15, 2026
    United States

    Eloralintide

    100 MT Jul 11, 2026
    United States

    Eloralintide

    1 MT Jul 8, 2026
    United States

    Eloralintide

    10  Jul 3, 2026
    United States

    eloralintide

    1 PCS Apr 22, 2026
    United Kingdom

    Eloralintide

    10 MG Mar 14, 2026
    United States

    Eloralintide

    1 G Feb 9, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.